Abbreviations & Acronyms AVF = arteriovenous fistula CI = confidence interval NTRP = non-transplanted renal patients OR = odds ratio RCD = renal chronic disease TRP = transplanted renal patients Objective: To compare complications of ultrasound-guided percutaneous renal biopsy using two needle gauges (16-G and 18-G). Methods: A total of 238 individuals with renal biopsy indication were included and randomly separated into two groups: ultrasound-guided percutaneous renal biopsy procedure carried out with a 16-G or 18-G needle. The adequacy of biopsy samples and post-procedure complications were compared between the two groups. Results: The procedures carried out with a 16-G needle collected fragments with a mean of 22.1 AE 10.8 glomeruli, and those carried out with an 18-G needle had a mean of 17.5 AE 9.4 glomeruli. Patients submitted to renal biopsies with a 16-G needle had a higher likelihood of having a complication (OR 5.1, 95% CI 1.7-15.4, P = 0.001). The overall mean volume of post-biopsy hematoma in patients with complications was significantly larger than those without complications (44 AE 56.1 mL vs 5.9 AE 6.6 mL; P < 0.001). Conclusions: Renal biopsies carried out by ultrasonography using an 18-G needle provide adequate histological analysis, showing a lower amount of glomeruli but with similar clinical quality as a 16-G needle. Furthermore, it is associated with a lower risk of procedure-related complications.
Introduction
Currently, RCD is a major public health problem worldwide. In Brazil, the prevalence of patients maintained on a chronic dialysis program has grown in recent years. The estimated total number of RCD patients in the country in 2014 was 112 004. 1 This number represents an increase of 20 000 patients in the past 4 years (92 091 in 2010). There has been an average annual increase in the number of RCD patients of 5% in the past 4 years. 1 Renal biopsy became an emerging tool for chronic renal failure screening in recent years for elucidation of various renal diseases.
The renal biopsy is the gold standard that contributes to making a diagnosis, a treatment selection and a prognostic evaluation of nephropathies by microscopic analysis, including immunohistochemically and/or histopathological examinations. 2 However, as it is an invasive method, biopsy of the kidney is not complication free. Among the postoperative complications, the most frequent are macrohematuria with or without the need of blood transfusion.
The most current technique consists of the use of automatic systems of biopsy guns with disposable needles or completely disposable systems of semi-automatic needles, associated with an ultrasound imaging examination (ultrasound-guided percutaneous renal biopsy). The use of ultrasonography makes biopsies of the kidney safer and easier, 3 such that it has become the standard method. 4 To carry out this biopsy, one needle is necessary and it can vary in gauge. In 2016, an American research group compared two different needle gauges based on the number of tissues obtained in biopsy with two needles, complication rates, and clinical and laboratory data. The potential for complications might be less using a 16-G needle, and no differences were found for the other parameters. 5 In contrast, Mai et al. reported that there was no significant difference in the total number of complications between 16-G and 18-G needle groups, but 16-G provides more glomeruli and renal tissue with adequate diagnosis. 6 Considering pathological evaluation, small biopsy needles (20-G and 22-G) do not provide sufficient material for diagnosis, and they increase the likelihood of repeat the biopsy. 7 Kidney biopsies are carried out under varying conditions, presenting variables that could potentially influence the yield and adequacy of tissue collected for analyses. Then, there is a need for constant improvement of the technique, as it is a procedure of unquestionable benefit and safety. 8 More established protocols are important for improving the quality of diagnoses; in addition, reducing complications might promote patient comfort. In the context, our objective was compare complications of ultrasound-guided percutaneous renal biopsy using two needle gauges (16-G and 18-G).
Methods

Study participants
This research was registered with Plataforma Brasil (http://pla taformabrasil.saude.gov.br), a national and unified database of research involving human subjects' records, and was approved by the institutional ethics committee and was carried out at Santa Casa Hospital, Belo Horizonte, Brazil. The aim of the present study was to assess ultrasound-guided percutaneous renal biopsy related with minor and major complications, by comparing different needle gauges (16-G and 18-G). The study sample was a consecutive sample consisting of 238 individuals with renal biopsy indication. All included participants signed informed consent. The gauge of needle (16-G and 18-G) used in this study was chosen in accordance with the frequency of use in renal biopsy protocols. The individuals were previously numbered and randomly separated into two groups according to the gauge of needle used in the procedure (16-G and 18-G) with the Excel computer program. The study was double blind. Patients were excluded from the study if they had coagulation disorders characterized by prothrombin activity <60%, an international normalized ratio >1.3 or platelets with a count <60 000/mm 3 . Besides that, people aged <12 years, without adequate access to having biopsy carried out, renal ectopia, congenital dysplasias, acute renal failure without a chronic component, polycystic kidneys, blood pressure level >160 9 100 mmHg, glucose >126 mg/dL and uncontrolled or disabling chronic obstructive pulmonary disease were also excluded.
Parameters of pre-biopsy
The following sociodemographic and clinical data were collected: age, sex, comorbid medical conditions and use of medications. Patients who had continuous use of anticoagulants were suspended 1 week before the biopsy was to take place. Before the biopsy, the researcher evaluated physical (cardiac frequency, arterial pressure and summary general examinations), radiographic (renal morphology and echogenicity) and laboratory (blood count, creatinine, both before and 12 h after the biopsy procedure and urine, before and three times after the biopsy procedure) conditions related with RCD. Stages of renal disease were evaluated by estimating the glomerular filtration rate using the Cockcroft-Gault formula for the creatinine test. 9, 10 All patients underwent ultrasonography before the renal biopsy.
Renal biopsy
All biopsies were carried out by the percutaneous technique with real-time ultrasound using Ultra-sound Xario XG (Toshiba America Medical Systems, Tustin, CA, USA) and an automated device for the automatic spring-loaded biopsy (Bard Magnum; Bard, Tempe, AZ, USA) by two expert ultrasonographers (MCBA and PRBA) after adequate local antisepsis and positioning of the individual, depending of the renal condition (transplanted or not). The biopsies were freehand biopsies with an ultrasound-guided needle that penetrates the skin with approximately 45°angulation. It was always oriented to the renal lower pole in the native kidneys and in the upper pole in the transplanted patients. The gauge of the needle used was in accordance with the random division. The biopsy fragments, a minimum of two per examination, were subjected to blind analysis, including histopathological and immunohistochemically analyses, by the Pathologic Anatomy Department of Santa Casa Hospital, Belo Horizonte, Brazil.
Parameters post-biopsy
The patients were reassessed immediately after biopsy. The volume of the perirenal hematoma formed was measured, by ultrasound, three times immediately after the biopsy procedure and was calculated using the following formula: V = 4/ 3 9 p 9 Rap 9 Rml 9 H, where V = volume, Rap = anteroposterior radius, Rml = mediolateral radius and H = height. 11 The final volume was the result of the average between three measurements. At 3 h, 12 h and 7 days after the procedure, ultrasonography was obtained of each patient and no dropouts were observed. Renal complications were categorized in accordance with David Sacks et al. in the Society of Interventional Radiology clinical practice guidelines, and included major complications, such as disabling intense pain, hemodynamic instability with hemotransfusion and hemotransfusion with embolization, and minor complications, such as arteriovenous fistula and intravesical coagulation. 12 All complications were analyzed immediately after the procedure and at three different times (3 h, 12 h and 7 days). In cases where an individual complained of severe pain, hyperemia, arterial hypertension or hypotension, complementary laboratory examinations were carried out.
Statistical analysis
A database was assembled using Statistical Package for the Social Sciences, version 21 
Results
The data were collected during 18 months. The sample of the present study consisted of 238 patients, being 115 (48.3%) women and 123 (51.7%) men, with a mean age of 40.17 AE 15.73 years and a median age of 41.0 years. A total of 134 (56.3%) individuals underwent renal biopsy with a 16-G needle and the other 104 (43.7%) using an 18-G needle. Participants of both groups did not differ in sex distribution or age. The 16-G group was composed of 110 (82%) NTRP and 24 (18%) TRP, whereas the 18-G group was composed of 64 (62%) NTRP and 40 (38%) TRP. The detailed demographic data is reported in Table 1 .
The procedures carried out with a 16-G needle included a mean of 22.1 AE 10.8 glomeruli (median of 22.5, variance of 117.6) in collected fragment of the biopsy, and those carried out with a 18-G needle included a mean of 17.5 AE 9.4 glomeruli (median of 17.0, variance of 89.4; P = 0.005, MannWhitney test). The 16-G group obtained three cases (2.23%) and 18-G group obtained eight cases (7.69%) of sampling with less than five glomeruli.
The total of complications presented in this study was 21% (50/238 individuals), being 74% of these total complications of the 16-G needle procedure. The total complications included NTRP in 44 individuals (88%) and TRP in six individuals (12%; P = 0.008, v 2 -test). The study reported 27 (11.3%) individuals that had major complications, of these 85.2% were of the group of patients submitted to the 16-G needle procedure (P = 0.001). The 16-G group had a total major complications rate of 17.1% versus 3.9% of the 18-G group. Of the minor complications were observed, 10.5% were seen in the 16-G group compared with 8.7% in the 18-G group. In the group that has the 18-G needle procedure, there were only 1.0% serious complications (hemodynamic instability with hemotransfusion and hemotransfusion with embolization) compared with 2.9% in the group with the 16-G needle procedure. All the patients who presented complications were hospitalized and stabilized, and were discharged from hospital in good health. There were no deaths. All complications are shown in Table 2 .
Patients (TRP and NTRP) who were submitted to renal biopsies with a 16-G needle had greater chances of complications when compared with individuals that had the 18-G needle procedure (OR 5.1, 95% CI 1.7-15.4; P = 0.001, Fisher's test). For TRP, the two needle gauges, 16-G and 18-G, did not show differences in the complication rates (OR 5.5, 95% CI 0.5-56.9; P = 0.14, Fisher's test). In contrast, NTRP showed higher rates of complications in patients submitted to 16-G biopsy in relation to patients submitted to 18-G biopsy (OR 4.5, 95% CI 1.3-15.8; P = 0.01, Fisher's test).
The volume of perirenal hematoma formed after biopsy seems to be related to the risk of post-procedure complications (Table 3 ). The mean of perirenal hematoma volume formed in individuals (16-G and 18-G groups) comparing patients with complications versus patients without complications was 44 AE 56.1 mL (median 30 mL) and 5.9 AE 6.6 mL (median 4 mL; P < 0.001, Mann-Whitney test), respectively. The relationship between post-biopsy complications and the various stages of renal disease, based on the calculated creatinine clearance (Cockcroft-Gault's formula), was not statistically significant.
Renal biopsies were carried out using four needle insertions in 56.7% of the patients and five insertions in 24.8% of the patients; that is, >80% of the biopsies were carried out using four or five needle insertions. The association between the number of needle insertions during the biopsy procedure and the rates of complications were not statistically significant (P = 0.73, Mann-Whitney test). There was also no statistically significant correlation between the number of needle insertions and the size of formed hematoma at 3 h, 12 h and 7 days post-procedure (P = 0.12 and P = 0.17, Mann-Whitney test).
Discussion
RCD is a major public health problem worldwide, and renal biopsy is a gold standard procedure that is used to obtain small pieces of kidney tissue to determine the cause, severity and possible treatment of a kidney disorder.
In the present study, we found a higher complication rate for NTRP when compared with TRP. This finding is in accordance with literature data, owing to various anatomical and/or physiopathological factors of the transplantation that allow technical facility in carrying out transplanted renal biopsy (more superficial renal topography, less tissue interposed between the kidney and the skin, reduced volume of tissues transfixed by the needle and therefore much better visualized because of less acoustic impedance). 13 In addition to this, biopsies using a 16-G needle showed higher complication rates than an 18-G needle. The literature shows variable rates of complications associated with renal biopsy.
Burstein et al. reported 14-G needle post-biopsy complications in 14.3% of the patients, 6.6% of whom were considered as minor (macrohematuria without the need for blood transfusion) and another 7.7% considered larger complications (hemorrhages requiring blood transfusion or other approaches).
14 Other authors reported indexes of complications associated with 14-G, 16-G and 18-G needles between 5% and 16%, macroscopic hematuria between 3% and 9%, and transfusion support between 0.1% and 3% of the cases. Accidental puncture of other organs or viscera is not common. [15] [16] [17] [18] [19] Komal et al. showed a number of 0-30 glomeruli per biopsied fragment (mean 9.42 AE 5.5) obtained by a 16-G needle against 0-19 glomeruli per fragment (mean 7.7 AE 4.4) by an 18-G needle. 20 Contrary to our study, we found larger numbers of glomeruli using the two different gauges of needles. Though we found that the numbers of glomeruli in the two groups were statistically significant, clinically, the sampling of as few as five glomeruli in each biopsy provides a good representation of the kidney. 21 Anuj et al. showed a mean of 17.5 glomeruli per biopsy fragment, and 4.6% of the fragments with less than five glomeruli in a sample of 81 patients biopsied with a 16-G needle. 18 Other authors found the mean number of glomeruli per biopsied fragment to be 15, 11 and nine glomeruli, respectively, with the use of 14-G, 16-G and 18-G needle gauges. 22 These authors found that patients submitted to the 14-G needle procedure presented more pain. Comparing 14-G with 18-G needles, studies showed that 88.9% of fragments biopsied with 14-G needles had five or more glomeruli compared with 82.9% in patients submitted to 18-G needles. However, the diagnostic conclusion was similar in both groups. 23 As the present study was concerned not only with recording the presence of macro-and microscopic hematuria, but also with searching for associated findings, it was noticed that all patients with symptomatic macroscopic hematuria had intravesical clots with ultrasonography, whereas those with asymptomatic hematuria not. Most of the studies did not subdivide patients who presented macroscopic hematuria after the procedure in patients with asymptomatic macroscopic hematuria (conservative management) and symptomatic macroscopic hematuria (those who required some medical approach). 4, 15, 18, 19, 24 Thus, the information regarding the formation of the intravesical clot and its analysis are impaired, as there is no standardization of information. Macroscopic hematuria is treated generically, without a specific approach.
The incidence of AVF after renal biopsy is variable, raging up to 16%, which is in accordance with the present study -3.4% of all biopsies. 25 Angiographic studies after renal biopsy showed the formation of AVF in 9-11% of the cases, whereas flowmetric Doppler study shows formation in 5% of the cases. In the follow up of patients with AVF from 16-G and 18-G needle renal biopsy, 95% presented spontaneous resolution. 26, 27 It is well accepted that AVF can be reliably diagnosed by Doppler ultrasound. 28 In recent years, new techniques for the imaging of vessels have been developed, based on the innovation of Doppler ultrasound technique that can be used without contrast, form high-sensitivity images with improved depth resolution, decrease artefacts and investigate smaller vessels, vessels with very low flow and superficial malformations. Examples of such techniques is advanced dynamic flow and superb microvascular imaging, and it seems that these have the potential to replace the Doppler. The presence of perirenal hematoma formation is very common in patients submitted to renal biopsy. 32 This finding shows that the presence of only perirenal hematoma is not a relevant factor. However, its volume, notably in the first hours after the procedure, can be determinant in the prediction and adequate follow up of the complications, as shown in the present study.
29-31
The important limitation of the present study relates to the pain measurement. Although the measure of pain that was used has face validity, capturing a measure of symptomatic distress that would be relevant to most patients, assessment of pain was subjective and an individual perception.
The present study showed that the conventional needles, commonly used to obtain biopsy specimens of the kidney, for the evaluation of diffuse renal disease perform well. Renal biopsies carried out by ultrasonography using an 18-G needle provided adequate histological analysis, showing lower amounts of glomeruli, but with similar clinical quality with a 16-G needle. In regard to 18-G needle procedures, this gauge showed lower complication rates when compared with 16-G needles. In addition, the size of the hematoma appears to be related to the rate of complications, and possibly hematomas with a volume >40 mL formed immediately after the biopsy is a predictor of complication.
